Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernovartis.com
English RSS Feed
Get the latest updates from English RSS Feed directly as they happen.
Follow now 75 followers
Latest posts
Last updated 2 days ago
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
2 days ago
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway...
Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility
9 days ago
Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility...
Novartis partners with Special Olympics World Winter Games Switzerland 2029
10 days ago
Novartis partners with Special Olympics World Winter Games Switzerland 2029 angilma1 Wed...
Full Circle: A Story of Growth, Purpose and Coming Home to Novartis
11 days ago
Full Circle: A Story of Growth, Purpose and Coming Home to Novartis...
Novartis erzielte im ersten Quartal mit prioritären Marken und Neueinführungen ein starkes Wachstum; Prognose für das Geschäftsjahr 2026 bekräftigt
11 days ago
Novartis erzielte im ersten Quartal mit prioritären Marken und Neueinführungen ein starkes...
Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed
11 days ago
Novartis delivered strong growth in priority brands and launches in Q1; FY...
Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria
12 days ago
Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for...
Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria
12 days ago
Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for...
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)
15 days ago
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)...
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)
15 days ago
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)...
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
15 days ago
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater...
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
15 days ago
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater...